|
Notification regarding unquoted securities - 4DX
|
15 June 2023 at 12:45pm
|
|
Results of Meeting
|
14 June 2023 at 2:00pm
|
|
EGM presentation and CEO address
|
14 June 2023 at 9:45am
|
|
Change in substantial holding
|
31 May 2023 at 2:50pm
|
|
Change in substantial holding
|
31 May 2023 at 2:50pm
|
|
Change in substantial holding
|
31 May 2023 at 2:50pm
|
|
Application for quotation of securities - 4DX
|
30 May 2023 at 11:35am
|
|
Update - Proposed issue of securities - 4DX
|
29 May 2023 at 2:55pm
|
|
4DMedical completes oversubscribed $25m SPP
|
29 May 2023 at 2:00pm
|
|
44Medical unveils VQ product at premier US lung conference
|
23 May 2023 at 9:45am
|
|
Change in substantial holding
|
18 May 2023 at 4:30pm
|
|
Change in substantial holding
|
18 May 2023 at 4:30pm
|
|
Change in substantial holding
|
18 May 2023 at 4:30pm
|
|
Ceasing to be a substantial holder
|
18 May 2023 at 4:30pm
|
|
4DMedical granted Authority to Operate at Harry S. Truman VA
|
18 May 2023 at 10:30am
|
|
Notice of Extraordinary General Meeting and Proxy Form
|
12 May 2023 at 9:30am
|
|
Cleansing Notice
|
10 May 2023 at 11:15am
|
|
Application for quotation of securities - 4DX
|
10 May 2023 at 11:05am
|
|
Target Market Determination
|
10 May 2023 at 10:45am
|
|
Prospectus
|
10 May 2023 at 10:40am
|
|
4DMedical Investor Webinar Details
|
8 May 2023 at 3:10pm
|
|
Proposed issue of securities - 4DX
|
8 May 2023 at 10:10am
|
|
Investor Presentation Capital Raise
|
8 May 2023 at 10:10am
|
|
4DMedical completes $20m Placement and launches SPP
|
8 May 2023 at 10:10am
|
|
Application for quotation of securities - 4DX
|
5 May 2023 at 1:50pm
|
|
4DMedical wins commercial pilot with US Dept of Defense
|
5 May 2023 at 12:30pm
|
|
Trading Halt
|
4 May 2023 at 10:25am
|
|
Pause in Trading
|
4 May 2023 at 10:00am
|
|
4DMedical conducts first commercial scan within VA
|
1 May 2023 at 10:10am
|
|
Appointment of Company Secretary
|
28 April 2023 at 12:15pm
|
|
Appendix 3Y - JL
|
27 April 2023 at 10:00am
|
|
Notification regarding unquoted securities - 4DX
|
27 April 2023 at 9:55am
|
|
Application for quotation of securities - 4DX
|
27 April 2023 at 9:55am
|
|
Late Lodgement ASX Appendices
|
27 April 2023 at 9:50am
|
|
Quarterly Activity Report and Appendix 4C for Q3 FY2023
|
26 April 2023 at 10:10am
|
|
Dr David Shulkin, MD, joins 4DMedical
|
13 April 2023 at 10:50am
|
|
4DX provides further info on US hospital SaaS contract
|
13 April 2023 at 10:25am
|
|
4DMedical signs first US hospital SaaS contract
|
5 April 2023 at 11:40am
|
|
S&P DJI Announces March 2023 Quarterly Rebalance
|
3 March 2023 at 5:25pm
|
|
4DMedical Reports 1H FY2023 Results
|
28 February 2023 at 11:10am
|
|
Appendix 4D and Half-Year Financial Report
|
28 February 2023 at 11:05am
|
|
Quarterly Activity Report and Appendix 4C for Q2 FY2023
|
31 January 2023 at 10:10am
|
|
Notification of cessation of securities - 4DX
|
11 January 2023 at 10:20am
|
|
Ceasing to be a substantial holder
|
23 December 2022 at 5:00pm
|
|
Appendix 3Y - AF
|
23 December 2022 at 4:15pm
|
|
Notification regarding unquoted securities - 4DX
|
23 December 2022 at 4:10pm
|
|
Appointment of Senior VP Business Development
|
8 December 2022 at 10:30am
|
|
S&P DJI Announces December 2022 Quarterly Rebalance
|
2 December 2022 at 5:30pm
|
|
4DMedical receives $9.4m from MRFF
|
29 November 2022 at 10:00am
|
|
Investor Presentation
|
8 November 2022 at 9:30am
|
